Experience, Longevity, Quality and Service.

Dr. Walling co-founded Collaborative Neuroscience Research (CNS) in 2000 to advance medical knowledge through the execution of clinical trials. His operational and strategic leadership has enabled the growth of CNS into one of the largest clinical research providers in the US. He is a principal investigator for many studies at the inpatient unit in Long Beach as well as the outpatient clinic in Garden Grove. Dr. Walling advises pharmaceutical companies in numerous ways including the creation of drug development plans, design and analysis of clinical trials in all phases, and preparation for interactions with regulatory agencies.

Work History

Dr. Walling has served as an investigator in over 600 trials, including over 100 Phase I trials, with many focusing on schizophrenia and cognition, areas in which he is recognized as a thought leader.

Before founding CNS, Dr. Walling was VP of Clinical Services at Psychiatric Management Resources & Stadt Solutions Pharmacy Corporation. He has also served as an Assistant Professor and Research Scientist in Psychiatry and Behavioral Sciences at the University of Texas Medical Branch at Galveston. Dr. Walling has clinical experience as a licensed psychologist and marriage, family, and child counselor.

Dr. Walling has authored dozens of articles on psychiatric indications that have been published in leading scientific journals. Dr. Walling also provides training to rater training companies for some of the most widely used psychiatric and cognitive rating scales including the Positive and Negative Syndrome Scale (PANSS).

Dr. Walling is a highly sought-after KOL in psychiatry and in digital device and software technologies. His pioneering work in small proof of concept studies within Phase I development programs has ensured the successful path for several drugs. He holds multiple advisory board memberships and consulting positions for sponsors.

Education
Dr. Walling received his doctorate in Counseling Psychology from the University of Southern California. He attended California State University, Long Beach, earning a master’s degree in Counseling as well as a bachelor’s degree in Psychology.

Dr. Botros joined CNS in 2008, bringing in over 10 years’ experience in clinical research. She leads operations for all CNS’s locations, ensuring policies and procedures are optimized and continuously reviewed to exceed the highest standards of industry expectations. Dr. Botros works relentlessly to achieve effective project planning and operational management for each trial. She makes sure that clinical research activities are fully compliant with federal regulations and ICH/GCP guidelines.

Work History

Prior to being elevated to her current role in 2020, Dr. Botros served as Director of Operations for the CNS Long Beach site for 10 years. She led the CNS Clinical Pharmacology Unit expansion to support both healthy normal volunteers and patient populations in early phase clinical trials and developed the associated standard operating procedures. From 2008 to 2010, Dr. Botros was Site Director for CNS’s Torrance site, managing the day-to-day operations of the research clinic and supervising the clinical team. Prior to joining CNS, Dr. Botros worked in Dermatology Research as a Clinical Research Fellow, completing almost 50 studies for over 20 pharmaceutical companies. Earlier on, she was a General Physician at the Alexandria Medical University Hospital as well as an obstetrician/Gynecologist at the Kafr Dawar Public Hospital in Alexandria, Egypt. Dr. Botros has published numerous clinical studies and poster presentations and has been a guest speaker for a variety of pharmaceutical companies.

Education

Dr. Botros received her medical degree from the Alexandria University School of Medicine in Egypt. She is fluent in English, French and Arabic.